Table 1.
Cohort characteristics
| Median (range) | Mean ± SD | ||
|---|---|---|---|
| Age | 41 (14–69) | 40.3 ± 20.4 | |
| Frequency | Percentage | ||
| Sex | |||
| Male | 8 | 66.7% | |
| Female | 4 | 33.3% | |
| Epicentre | |||
| Soft tissue | 6 | 50% | |
| Ribs | 4 | 33.3% | |
| Lungs | 2 | 13.3% | |
| Pathology | |||
| Sarcoma | 5 | 41.6% | |
| Ewing sarcoma | 2 | 16.7% | |
| Synovial sarcoma | 1 | 8.3% | |
| Epithelioid sarcoma | 1 | 8.3% | |
| Spindle cell sarcoma | 1 | 8.3% | |
| Carcinoma | 3 | 25% | |
| Squamous cell carcinoma | 1 | 8.3% | |
| Adenocarcinoma | 2 | 16.7% | |
| Others | 4 | 33.3% | |
| ASA grade | |||
| ASA1 | 8 | 66.7% | |
| ASA2 or above | 4 | 33.3% | |
| Preoperative treatment | |||
| Yes | 4 | 36.4% | |
| No | 8 | 66.7% | |
| Resection | |||
| Rib resection | 10 | 83.3% | |
| Single rib | 3 | 25% | |
| Multiple ribs | 7 | 58.3% | |
| Sternum | 1 | 8.3% | |
| Lung resection | 4 | 33.3% | |
| Wedge resection | 2 | 16.7% | |
| Lobectomy | 2 | 16.7% | |
| Diaphragm excision | 2 | 16.7% | |
| Reconstruction | |||
| Primary closure | 2 | 16.7% | |
| Mesh | 10 | 83.3% | |
| Mesh only | 6 | 50% | |
| Mesh-bone cement | 4 | 33.3% | |
| Margin negative resection | 12 | 100% | |
| Postoperative course | |||
|
Minor complications (TM&M Grade I/II) |
4 | 33.3% | |
| Major (TM&M Grade III or above) or perioperative mortality or readmission rate in 90 days | 0 | 0 | |
| Postoperative pulmonary complications | 2 | 16.7% | |
| Wound-related complications | 1 | 8.3% | |
| Adjuvant treatment | |||
| Both postoperative chemotherapy and radiotherapy | 3 | 25% | |
| Postoperative radiotherapy only | 2 | 16.7% | |
| Postoperative chemotherapy only | 2 | 16.7% | |
SD, standard deviation; ASA grade, American Society of Anesthesiologists risk grade; TM&M grade, Thoracic Surgical Morbidity and Mortality grade